Skip to main content
OpenTrials
Completed

NCT Number: NCT02151162

Happy Nurse Project: Lifestyle Interventions to Maintain Healthy Mental State in Hospital Nurses

The study is to explore the effectiveness of omega-3 fatty acids and mindfulness-based stress management program to maintain healthy mental state in hospital nurses. The participants will be junior nurses who work in inpatient wards and are not clinically depressed. The participants will be randomly allocated to four intervention arms: 1) Mindfulness-based stress management program plus omega-3 fatty acids pills ; 2) Mindfulness-based stress management program plus placebo pills; 3) Psychoeducation leaflet plus omega-3 fatty acids pills; and 4) Psychoeducation leaflet plus placebo pills. Thirty participants will be allocated to each arm. These interventions will terminate until three months from registration for each participant.

Information about depression and anxiety symptoms (primary outcome), insomnia, burnout, presenteeism, quality of life, sick leave, consultation about mental state of herself, and oxidative stress will be collected at 3 months, 6 months (primary time point) and 12 months from registration for each participant.

Completed

Looking for future studies?

Notify Me

Key information

Age range

20 year–59 year

Sex eligibility

Female

Study type

Interventional

Phase

Not applicable

Primary location

National Center of Neurology and Psychiatry, Kodaira, Tokyo, Japan

Loading trial locations.

About this study

The study is to explore the effectiveness of omega-3 fatty acids and mindfulness-based stress management program to maintain healthy mental state in hospital nurses. The participants will be junior nurses who work in inpatient wards at four general hospitals in Tama region in Tokyo, and are not clinically depressed based on the score of the Hospital Anxiety and Depression scale. The participants will be randomly allocated to four intervention arms: 1) Mindfulness-based stress management program plus omega-3 fatty acids pills; 2) Mindfulness-based stress management program plus placebo pills; 3) Psychoeducation leaflet plus omega-3 fatty acids pills; and 4) Psychoeducation leaflet plus placebo pills. Thirty participants will be allocated to each arm. These interventions will terminate until 3 months from registration for each participant. Stress management program will be conducted by senior nurses in four individual sessions within these three months. Psychoeducation leaflet will include information about screening of stress, sleep hygiene, relaxation, and a list of consultants about mental health.

Information about depression and anxiety symptoms (primary outcome), insomnia, burnout, presenteeism, quality of life, numbers of incident and accident at work, sick leave and consultation about mental state of herself, concentration of fatty acids in serum and oxidative stress will be collected at 3 months, 6 months (primary time point) and 12 months from registration for each participant. The primary outcome will be assessed by blind raters through telephone.

The outcomes will be compared between arms including stress management program and those without, and between arms including omega-3 fatty acids and those without, by using mixed model repeated measures model.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Work for inpatient wards in among four general hospitals in Tama region, Japan, including: National Center of Neurology and Psychiatry Hospital, National Disaster Medical Center, Tokyo Metropolitan Tama Medical Center, and Tama-Hokubu Medical Center
  • Nurses without administration work
  • Give written consent in the participation of the study

Exclusion criteria

  • Have plans to take sick leave, leave for other reasons or retirement within 26 weeks from the entry to the study
  • Take structured psychotherapy (e.g. cognitive behavioral therapy, interpersonal therapy, and brief psychodynamic therapy) at the entry
  • See a physician regularly in order to treat any mood or anxiety disorders primarily at the entry
  • Take antidepressants, mood stabilizers, anticonvulsants or antipsychotics at the entry
  • Have taken nutrient supplement including omega-3 fatty acids for 4 or more weeks within 52 weeks from the entry
  • Clinically depressed, based on the total score of 11 or more on the Hospital Anxiety and Depression Scale - Depression Subscale and the total score of 15 or more on the Primary Health Care Questionnaire
  • Consume 4 times or more of fish as the main course of meal per week
  • Take anticoagulant drugs at the entry or have previous history of stroke or myocardial infarction
  • Judged ineligible by research coordinator due to any reason

Treatment and study plan

Mindfulness-based stress management program

Behavioral

Mindfulness-based stress management program will be conducted by senior nurses in four individual sessions within these three months. Senior nurses have taken a 7-hour workshop including lectures and role-playing sessions. The detailed manual and videos including lectures will be provided to the senior nurses.

Omega-3 fatty acids pills

Dietary Supplement

Omega-3 fatty acids pills will include 1200 mg of eicosapentaenoic acid and 600 mg of docosahexaenoic acid per day.

Psychoeducation leaflet

Behavioral

Psychoeducation leaflet will include information about screening of stress, sleep hygiene, relaxation, and a list of consultants about mental health.

Placebo pills

Dietary Supplement

Placebo pills will include rapeseed oil, soybean oil, olive oil and fish oil.

Primary outcomes

  1. Blindly-rated depression and anxiety severity: Hospital Anxiety and Depression Scale (HADS)

    Time frame: 26 weeks

    The total score of the HADS (HADS-T) ranges from 0 to 42, with higher scores indicating more symptoms. The HADS has two sub scores, each ranging from 0 to 21: HADS-D (depression) and HADS-A (anxiety). The total score will be used as the severity of depression and anxiety symptoms in the present study.

Secondary outcomes

  1. Blindly-rated depression and anxiety severity: Hospital Anxiety and Depression Scale (HADS)

    Time frame: 13 weeks

  2. Blindly-rated depression and anxiety severity: Hospital Anxiety and Depression Scale (HADS)

    Time frame: 52 weeks

  3. Major depressive episode: Primary Care Evaluation of Mental Disorders (PRIME-MD)

    Time frame: 26 weeks

    Major depressive episode will be ascertained using the Primary Care Evaluation of Mental Disorders (PRIME-MD) algorithm with the depression module of the Patient Health Questionnaire (PHQ-9). The PHQ-9 was developed as a self-report version of the PRIME-MD which aims at Diagnostic and Statistical Manual of Mental Disorders 4th edition (DSM-IV) diagnosis of several common mental disorders.

  4. Major depressive episode: Primary Care Evaluation of Mental Disorders (PRIME-MD)

    Time frame: 13 weeks

  5. Major depressive episode: Primary Care Evaluation of Mental Disorders (PRIME-MD)

    Time frame: 52 weeks

  6. Depression severity: Personal Health Questionnaire-9 (PHQ-9)

    Time frame: 26 weeks

    Personal Health Questionnaire-9 is a 9-item structured questionnaire to measure depression severity.

  7. Depression severity: Personal Health Questionnaire-9 (PHQ-9)

    Time frame: 13 weeks

  8. Depression severity: Personal Health Questionnaire-9 (PHQ-9)

    Time frame: 52 weeks

  9. Anxiety severity: Generalized Anxiety Disorder Assessment (GAD-7)

    Time frame: 26 weeks

    The GAD-7 consists of 7 items, and the total score ranges from 0 to 21.

  10. Anxiety severity: Generalized Anxiety Disorder Assessment (GAD-7)

    Time frame: 13 weeks

  11. Anxiety severity: Generalized Anxiety Disorder Assessment (GAD-7)

    Time frame: 52 weeks

  12. Insomnia severity: Insomnia Severity Index (ISI)

    Time frame: 26 weeks

    The ISI is now considered a standard measure of the global severity of insomnia and used in many studies. The total score between 8-14 indicates subthreshold insomnia; and 15-28, clinical insomnia. The total score of the ISI will be used as the severity of insomnia in the study.

  13. Insomnia severity: Insomnia Severity Index (ISI)

    Time frame: 13 weeks

  14. Insomnia severity: Insomnia Severity Index (ISI)

    Time frame: 52 weeks

  15. Somatic symptoms: The Bradford Somatic Inventory (BSI)

    Time frame: 26 weeks

    The BSI is a 44-item questionnaire for females about symptoms experienced in the previous month, which was designed to detect physical symptoms commonly related to depressed patients.

  16. Somatic symptoms: The Bradford Somatic Inventory (BSI)

    Time frame: 13 weeks

  17. Somatic symptoms: The Bradford Somatic Inventory (BSI)

    Time frame: 52 weeks

  18. Presenteeism: World Health Organization Heath and Work Performance Questionnaire (HPQ)

    Time frame: 26 weeks

    The HPQ is a self-report instrument designed to estimate the workplace costs of health problems in terms of self-reported reduced job performance (presenteeism).

  19. Presenteeism: World Health Organization Heath and Work Performance Questionnaire (HPQ)

    Time frame: 13 weeks

  20. Presenteeism: World Health Organization Heath and Work Performance Questionnaire (HPQ)

    Time frame: 52 weeks

  21. Burnout: Maslach Burnout Inventory (MBI)

    Time frame: 26 weeks

    The MBI is a self-report measure with 22 items and is calculated into three sub-domains such as emotional exhaustion, depersonalization and personal accomplishment.

  22. Burnout: Maslach Burnout Inventory (MBI)

    Time frame: 13 weeks

  23. Burnout: Maslach Burnout Inventory (MBI)

    Time frame: 52 weeks

  24. Quality of Life: EuroQol (EQ-5D)

    Time frame: 26 weeks

    EQ-5D is a standardised instrument for use as a measure of health outcome. Applicable to a wide range of health conditions and treatments.

  25. Quality of Life: EuroQol (EQ-5D)

    Time frame: 13 weeks

    EQ-5D is a standardised instrument for use as a measure of health outcome. Applicable to a wide range of health conditions and treatments.

  26. Quality of Life: EuroQol (EQ-5D)

    Time frame: 52 weeks

    EQ-5D is a standardised instrument for use as a measure of health outcome. Applicable to a wide range of health conditions and treatments.

Other outcomes

  1. Adverse events

    Time frame: 13 weeks

    Information about any possible adverse events will be collected during the intervention period.

Sponsors and collaborators

Lead sponsor

National Center of Neurology and Psychiatry, Japan

Other

Registry information

Official study title

Mindfulness-Based Stress Management Program and Omega-3 Fatty Acids to Maintain Healthy Mental State in Hospital Nurses: Multi-Center Factorial-Design Randomized Controlled Trial Happy Nurse Project

Acronym: HNP

Important dates

Study start
2014
Primary completion
2016
Study completion
2016
First posted
May 30, 2014
Registry last updated
Aug 22, 2018

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.